FASCIOLIASIS MARKET ANALYSIS

Fascioliasis Market, By Drug (Triclabendazole, Albendazole, and Nitazoxanide), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), And by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Mar 2023
Code : CMI5596
Pages :160
Formats :
Excel and PDF
Industry : Pharmaceutical

Regional Analysis

Global Fascioliasis Market- Regional Analysis

Among regions, Africa is estimated to hold a dominant position in global fascioliasis market over the forecast period. Europe holds 31.1% of market share due to increasing prevalence of fascioliasis in the region. According to data published by Springer Journal, in April 2018, the prevalence of fascioliasis in Africa was 5.9% in the systematic review of 2018.

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC Countries, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa